1
|
Jethani PM, Toglia J, Foster ER. Cognitive Self-Efficacy in Parkinson's Disease. OTJR-OCCUPATION PARTICIPATION AND HEALTH 2024; 44:625-631. [PMID: 37905522 PMCID: PMC11408982 DOI: 10.1177/15394492231206346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2023]
Abstract
Cognitive self-efficacy (CSE), one's belief in their ability to control their cognitive performance, is important for participation in daily activities and rehabilitation. This study aims to understand how Parkinson's disease (PD) affects CSE. The Cognitive Self-Efficacy Questionnaire (CSEQ) was administered to 47 non-demented PD and 52 healthy comparison (HC) participants. Groups were compared on their self-reported ability to recognize (Part 1) and manage (Part 2) cognitive symptoms and to perform cognitively complex functional activities (Part 4). Relationships between CSEQ scores and individual characteristics were assessed within PD. The PD group had lower CSEQ scores than the HC group for all Parts. Within PD, Part 2 scores were lower than Parts 1 and 4, and worse depressive symptoms and higher medication dosage correlated with lower CSE. People with PD may have low CSE, which can contribute to participation restrictions and reduced engagement in treatment. Occupational therapists should consider CSE with clients with PD.
Collapse
Affiliation(s)
- Pooja M. Jethani
- Louisiana State University of Health Sciences, Shreveport, LA, USA
| | | | | |
Collapse
|
2
|
Machado Sotomayor MJ, Arufe-Giráldez V, Ruíz-Rico G, Navarro-Patón R. Music Therapy and Parkinson's Disease: A Systematic Review from 2015-2020. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:11618. [PMID: 34770129 PMCID: PMC8582661 DOI: 10.3390/ijerph182111618] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/23/2021] [Revised: 10/28/2021] [Accepted: 11/02/2021] [Indexed: 12/05/2022]
Abstract
Parkinson's disease can be approached from various points of view, one of which is music therapy-a complementary therapy to a pharmacological one. This work aims to compile the scientific evidence published in the last five years (2015-2020) on the effects of music therapy in patients with Parkinson's disease. A systematic review has been performed using the Web of Science and Scopus databases with the descriptors "music therapy" and "Parkinson's disease". A total of 281 eligible articles were identified, which, after applying the inclusion and exclusion criteria, were reduced to 58 papers. The results display a great diversity of evidence, confirming positive effects on various spheres. All mentioned patients with Parkinson's disease had experienced different music therapy programs. Some studies focused on the motor component, which can be addressed through listening, body rhythm, and rhythmic auditory stimulation. Other studies confirm effects on communication, swallowing, breathing, and the emotional aspect through programs that focus on singing, either individually or in groups, in order to improve the quality of life of people with PD. It was concluded that music therapy programs can achieve improvements in various areas of patients with Parkinson's.
Collapse
Affiliation(s)
| | - Víctor Arufe-Giráldez
- Department of Specific Teaching Training and Research and Diagnosis Methods in Education, University of A Coruña, 15001 A Coruña, Spain
| | - Gerardo Ruíz-Rico
- Department of Education, Educational Sciences Faculty, University of Almería, 04120 Almería, Spain;
| | - Rubén Navarro-Patón
- Department of Applied Learning, Faculty of Teacher Training, Universidade de Santiago de Compostela, 15705 Santiago de Compostela, Spain;
| |
Collapse
|
3
|
Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression. Neuropsychol Rev 2021; 32:149-160. [PMID: 33860906 DOI: 10.1007/s11065-021-09502-7] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 03/24/2021] [Indexed: 12/19/2022]
Abstract
Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease (PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia (PDD). Mild cognitive impairment (MCI) has been identified as a transitional state between normal cognition and dementia. Although PD-MCI and its cognitive correlates have been increasingly studied as a risk indicator for development of PDD, investigations into the PD-MCI construct have yielded heterogeneous findings. Thus, a typical PD-MCI cognitive profile remains undefined. The present meta-analysis examined published cross-sectional studies of PD-MCI and cognitively normal PD (PD-CN) groups to provide aggregated effect sizes of group test performance by cognitive domain. Subsequently, longitudinal studies examining PD-MCI to PDD progression were meta-analyzed. Ninety-two cross-sectional articles of PD-MCI vs. PD-CN were included; 5 longitudinal studies of PD-MCI conversion to PDD were included. Random effects meta-analytic models were constructed resulting in effect sizes (Hedges' g) for cognitive domains. Overall performance across all measures produced a large effect size (g = 0.83, 95% CI [0.79, 0.86], t2 = 0.18) in cross-sectional analyses, with cognitive screeners producing the largest effect (g = 1.09, 95% CI [1.00, 1.17], t2 = 0.19). Longitudinally, overall measures produced a moderate effect (g = 0.47, 95% CI [0.40, 0.53], t2 = 0.01), with measures of executive functioning exhibiting the largest effect (g = 0.70, 95% CI [0.51, 0.89], t2 = 0.01). Longitudinal effects were made more robust by low heterogeneity. This report provides the first comprehensive meta-analysis of PD-MCI cognitive outcomes and predictors in PD-MCI conversion to PDD. Limitations include heterogeneity of cross-sectional effect sizes and the potential impact of small-study effects. Areas for continued research include visuospatial skills and visual memory in PD-MCI and longitudinal examination of executive dysfunction in PD-MCI.
Collapse
|
4
|
Camargo CHF, Ladeira MA, Serpa RA, Jobbins VA, Filho CRP, Welling LC, Teive HAG. The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia. Am J Alzheimers Dis Other Demen 2018; 34:1533317518802461. [PMID: 30286613 PMCID: PMC10852430 DOI: 10.1177/1533317518802461] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Patients with Parkinson disease dementia (PDD) have deficits resulting mainly from frontostriatal dysfunction. The aim of this study was to assess the effectiveness of reality orientation therapy (ROT) combined with drug therapy (acetylcholinesterase inhibitors) in PDD treatment and compare it with that of drug therapy alone. Patients (n = 12) with a diagnosis of PDD were divided into 2 groups: group A-drug therapy and ROT; group B-drug therapy alone. Reality orientation therapy was applied weekly for 6 months, and patients were assessed during the same period. Significant improvements in frontostriatal deficits were observed in the group that received the combined therapy, as shown mainly by the scores in verbal fluency in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery ( P = .02) and in attention in Scales for outcomes of Parkinson's Disease-Cognition ( P = .021) and Clock Drawing Test ( P = .037). Patients who received only medication had worse results in constructional praxis recall in the CERAD battery ( P = .037). Our results indicate that ROT may help in the treatment of frontostriatal cognitive deficits and can potentially be used to complement drug therapy.
Collapse
Affiliation(s)
| | - Marcelo Araújo Ladeira
- 1 Neurology Service, Hospital Universitário, State University of Ponta Grossa, Ponta Grossa, Brazil
| | - Rafael Arthur Serpa
- 1 Neurology Service, Hospital Universitário, State University of Ponta Grossa, Ponta Grossa, Brazil
| | - Vinicius Aguiar Jobbins
- 1 Neurology Service, Hospital Universitário, State University of Ponta Grossa, Ponta Grossa, Brazil
| | - Carlos Rory Pucci Filho
- 1 Neurology Service, Hospital Universitário, State University of Ponta Grossa, Ponta Grossa, Brazil
| | | | - Hélio Afonso Ghizoni Teive
- 2 Movement Disorders Unit, Neurology Service, Hospital de Clínicas-Federal University of Parana, Curitiba, Brazil
| |
Collapse
|
5
|
Camargo CHF, Bronzini A, Tolentino EDS, Medyk C, Schultz-Pereira GL. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease? ARQUIVOS DE NEURO-PSIQUIATRIA 2018; 76:145-149. [PMID: 29809231 DOI: 10.1590/0004-282x20180003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Accepted: 11/22/2017] [Indexed: 11/22/2022]
Abstract
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery was created to assess cognitive impairment in Alzheimer's disease (AD) but it is widely-used for various dementias. The aim of this study was to analyze the efficacy of using the CERAD battery in the assessment of patients with Parkinson's disease. Forty-nine patients with Parkinson's disease were divided into two groups (one with dementia and one without) using the Movement Disorder Society criteria for Parkinson's disease dementia. Cognitive deficits were assessed with the Clinical Dementia Rating Scale as the gold standard, and the CERAD. The ROC curve for the CERAD battery had an area under the curve = 0.989 (95% CI = 0.967 - 1, p<0.0001). Among the CERAD subtests, verbal fluency had the worst accuracy, and word list learning had the best accuracy. Despite the limits of this study, the CERAD battery can be efficient for assessment of cognitive deficits in Parkinson's disease patients.
Collapse
Affiliation(s)
- Carlos Henrique Ferreira Camargo
- Serviço de Neurologia, Hospital Universitário Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil
| | - Augusto Bronzini
- Serviço de Neurologia, Hospital Universitário Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil
| | - Eduardo de Souza Tolentino
- Serviço de Neurologia, Hospital Universitário Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil
| | - Camila Medyk
- Serviço de Neurologia, Hospital Universitário Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil
| | - Gustavo Leopold Schultz-Pereira
- Serviço de Neurologia, Hospital Universitário Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil
| |
Collapse
|
6
|
Almeida KJ, de Macêdo LP, Lemos de Melo Lobo Jofili Lopes J, Bor-Seng-Shu E, Campos-Sousa RN, Barbosa ER. Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease. J Geriatr Psychiatry Neurol 2017; 30:261-266. [PMID: 28747137 DOI: 10.1177/0891988717720298] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
INTRODUCTION It was proposed to modify the Pfeffer questionnaire (PQ) for functional assessment in patients with Parkinson disease (PD). AIM To determine the cutoff score for diagnosis of functional impairment in patients with PD by modified PQ (mPQ). METHODS A total of 110 patients with PD were enrolled into the study, and a neuropsychological test battery was performed to assess their cognitive status. Regarding functional assessment, the mPQ has been applied, and their results were compared to the functional assessment by Informant Questionnaire on Cognitive Decline in the Elderly adapted for use in Brazil (IQCODE-BR). The statistical analysis was accomplished through receiver operating characteristic (ROC) curve with evaluation of the area under the curve, sensitivity, and specificity of the new cutoff point. RESULTS Eighty-nine patients with PD were evaluated with a mean age of 63.69 ± 9.14 years. Cognitive status categorization was 28.10% as normal, 44.94% as mild cognitive impairment, and 26.96% of patients as dementia associated with PD. The average score on PQ was 3.49 ± 4.79 and on the mPQ 2.56 ± 3.49. In IQCODE-BR, the average score was 6.75 ± 32.72. The ROC curve for the new cutoff point presented 47.4% sensitivity, 88.10% specificity, and 0.757 of area under the curve, with a standard deviation of 0.055 (95% confidence interval: 0.650-0.864). CONCLUSION 3.5 is proposed as the cutoff point to define functional impairment in patients with PD by mPQ.
Collapse
Affiliation(s)
- Kelson James Almeida
- 1 Department of Neurology, University of São Paulo, Sao Paulo, Brazil.,2 Department of Neurology, Facid-Devry University of Medicine, Teresina, Piauí, Brazil.,3 Department of Neurology, Federal University of Piauí, Teresina, Piauí, Brazil
| | | | | | | | | | | |
Collapse
|
7
|
Machado FA, Rieder CR, Hilbig A, Reppold CT. Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery. Dement Neuropsychol 2016; 10:296-302. [PMID: 29213472 PMCID: PMC5619268 DOI: 10.1590/s1980-5764-2016dn1004007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background Parkinson's disease (PD) shows symptoms involving motor and non-motor
complications, including cognitive and behavioral changes, such changes
might to contraindicate deep brain stimulation surgery (DBS). Objective The aim of study was to investigate the neuropsychological profile of
patients with PD in a waiting list for DBS. Methods The neuropsychological evaluation was held in 30 patients of the ISCMPA
Movement Disorders Clinic, with surgical indication based on the criteria of
the responsible neurologists, in the period of 12 months. Instruments used:
MMSE, FAB, MoCA, BDI, Semantic Verbal Fluency, PDQ-39, PDSS; and the UPDRS
and Hoehn-Yahr scale. Results The patients were mostly male (66.7%) with a mean age of 59.37 (SD 10.60) and
disease duration 9.33 (SD 4.08). There was cognitive impairment in 56.7% of
patients by FAB and 76.7% by MoCA. Conclusion Even in the earliest stages of the disease, there is the incidence of
non-motor symptoms, especially in those subjects who had an early onset of
the disease.
Collapse
Affiliation(s)
| | | | - Arlete Hilbig
- Universidade Federal de Ciências da Saude de Porto Alegre, Porto Alegre, RS Brazil
| | | |
Collapse
|
8
|
Fonseca LC, Tedrus GMAS, Rezende ALRA, Giordano HF. Coherence of brain electrical activity: a quality of life indicator in Alzheimer’s disease?Coerência da atividade elétrica cerebral: indicador da qualidade de vida na doença de Alzheimer? ARQUIVOS DE NEURO-PSIQUIATRIA 2015; 73:396-401. [DOI: 10.1590/0004-282x20150035] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2014] [Accepted: 01/08/2015] [Indexed: 11/21/2022]
Abstract
Objective To investigate the relationships between quality of life (QOL) and clinical and electroencephalogram (EEG) aspects in patients with Alzheimer’s disease (AD). Method Twenty-eight patients with mild or moderate AD, 31 with Parkinson’s disease (PD), and 27 normal controls (NC) were submitted to: CERAD neuropsychological battery, Hamilton Depression and Anxiety Rating Scales, Functional Activities Questionnaire, QOL scale for patients with AD, and quantitative EEG measures. Results AD and PD patients had similar QOL (31.0 ± 5.8; 31.7 ± 4.8, respectively), worse than that of NC (37.5 ± 6.3). AD patients had lower global interhemispheric theta coherence (0.49 ± 0.04; 0.52 ± 0.05; 0.52 ± 0.05; respectively) than PD and NC. Multiple linear regression for QOL of AD patients revealed that global interhemispheric theta coherence, and Hamilton depression scores were significant factors (coefficients; 58.2 and -0.27, respectively; R2, 0.377). Conclusion Interhemispheric coherence correlates with QOL regardless of cognitive and functional variables and seems to be a neurophysiological indicator of QOL in AD patients.
Collapse
|
9
|
Sanyal J, Banerjee TK, Rao VR. Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study. Am J Alzheimers Dis Other Demen 2014; 29:630-6. [PMID: 24771763 PMCID: PMC10852774 DOI: 10.1177/1533317514531442] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Depression and cognitive impairment are frequent manifestations in Parkinson's disease (PD). Although a few longitudinal studies have reported on depression and dementia in PD, there is a yet a lack of such studies in India. This 7-year longitudinal study is a hospital-based prospective case (n = 250)-control (n = 280) study. In all, 36.8% had PD with no cognitive impairment (PD-Normal), 27.2% of the patients with PD were affected by dementia (PDD), and 36% of the remaining patients with PD had mild cognitive impairment (PD-MCI) at baseline. After 7 years of evaluation, 32 new patients, 12 patients from the PD-MCI group and 9 patients from the PD-Normal group, were diagnosed with dementia. The 7-year prevalence rate for dementia was estimated to be 49.28%. In the Indian population, an early onset of dementia is noted among patients with PD, with the age of onset being less than 55 years. Patients with early-onset PDD showed depression symptoms that differed significantly from the controls of the same age-group. There was a major difference in verbal fluency, word list recall, constructional praxis and recall, word list recognition, abridged Boston Naming Test, word list memory with repetition, and Mini-Mental State Examination between PD-MCI and PDD groups. Hallucinations before baseline (odds ratio [OR] = 4.427, 95% confidence interval [CI] = 2.122-9.373), akinetic/tremor dominancy (OR = 0.380, 95%CI = 0.149-0.953), and asymmetrical disease onset (OR = 0.3285, 95%CI = 0.1576-0.685) can be considered as risk factors for patients with dementia. Patients with early-onset PD might be more prone to complex depression and dementia. As the disease progresses, akinetic-dominant PD, early hallucinations, and asymmetrical disease onset are the potential risk factors for the development of dementia in patients with PD.
Collapse
Affiliation(s)
- Jaya Sanyal
- Department of Anthropology, University of Delhi, New Delhi-110007, India
| | - Tapas Kumar Banerjee
- Department of Neurology, National Neurosciences Centre, Kolkata, West Bengal, India
| | | |
Collapse
|
10
|
Karrasch M, Laatu S, Martikainen K, Marttila R. CERAD test performance and cognitive impairment in Parkinson's disease. Acta Neurol Scand 2013; 128:409-13. [PMID: 23668316 DOI: 10.1111/ane.12138] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/18/2013] [Indexed: 11/29/2022]
Abstract
OBJECTIVES Many patients with Parkinson's disease (PD) develop mild cognitive impairment (PD-MCI) and dementia (PDD). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neurocognitive test battery was originally developed to identify early Alzheimer's disease, but it has become a widely used screening instrument also for other types of dementia. The aim of the study was to examine differences in CERAD test performances between cognitively intact and impaired PD patients. MATERIALS AND METHODS Eighty-eight PD patients participating in a rehabilitation course were studied. The Clinical Dementia Rating (CDR) was used to assess cognitive impairment. Sixty-six patients were cognitively intact and 22 had cognitive impairment (≥1 in two or more domains or a sum of boxes score of ≥3). The Finnish CERAD test battery was used to measure cognitive functions in seven different domains (language functions, verbal learning, visuospatial functions, delayed recall, memory consolidation, recognition memory, and executive functions). RESULTS There were significant differences between the cognitively intact and impaired patients in six CERAD subtests (wordlist learning sum, wordlist delayed recall, constructional praxis recall, clock drawing, verbal fluency and constructional praxis copy) when controlling for covariates (disease duration, motor symptoms, age, and education). No differences were observed in memory consolidation scores. CONCLUSIONS The results indicate that mild cognitive impairment in PD is related to deficits in memory, executive functions, and visuospatial functions. The memory deficit is non-amnestic and does not entail accelerated forgetting. CERAD shows promise in identifying PD patients with cognitive impairment and increased risk of dementia.
Collapse
Affiliation(s)
- M. Karrasch
- Department of Psychology and Logopedics; Abo Akademi University; Turku Finland
| | - S. Laatu
- Outpatient Ward of Neuropsychiatry; University Hospital of Turku; Turku Finland
| | - K. Martikainen
- The Finnish Parkinson Foundation; Turku Finland
- The Finnish Parkinson Association; Turku Finland
| | - R. Marttila
- Department of Neurology; University of Turku; Turku Finland
| |
Collapse
|
11
|
Mild cognitive impairment in Parkinson's disease: a review of current concepts. Neurol Res Int 2013; 2013:576091. [PMID: 23936650 PMCID: PMC3713320 DOI: 10.1155/2013/576091] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2013] [Accepted: 06/11/2013] [Indexed: 11/21/2022] Open
Abstract
Mild Cognitive Impairment in Parkinson's Disease (PD-MCI) is common and may be associated with accelerated progression to dementia. Considering the importance of this emerging entity, new diagnostic criteria have recently been proposed. Early recognition and accurate classification of PD-MCI could offer opportunities for novel therapeutic interventions. This review discusses current definitions for PD-MCI, the screening tools used, the pattern of cognitive deficits observed, and the predictors of cognitive decline and transition to Parkinson's Disease Dementia. Emerging biomarkers, which may aid diagnosis, are also explored and the role of novel treatment options is considered.
Collapse
|
12
|
Yubero R. [Neuropsychological characteristics and diagnostic approach to Parkinsońs disease dementia and Lewy body dementia]. Rev Esp Geriatr Gerontol 2011; 46 Suppl 1:12-8. [PMID: 22152909 DOI: 10.1016/j.regg.2011.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
When approaching the neurophysiological characteristics and diagnostic approach to Parkinson's disease dementia (PDD) and Lewy body dementia (LBD), the first idea that comes to mind is that both types of dementia fall within the group of subcortical dementias, with the practical implications that this observation entails. We should therefore leave our knowledge of Alzheimer's dementia and other cortical dementias to one side as, in most cases, these forms of dementia do not correspond clinically or diagnostically to subcortical dementias. Therefore, the clinical and therapeutic approach of PDD and LBD differs from that of cortical dementias in form, if not in essence.
Collapse
Affiliation(s)
- Raquel Yubero
- Unidad de Memoria, Servicio de Geriatría, Hospital Clínico San Carlos, Madrid, España.
| |
Collapse
|
13
|
Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ. Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord 2011; 26:629-36. [DOI: 10.1002/mds.23592] [Citation(s) in RCA: 94] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Revised: 10/26/2010] [Accepted: 11/22/2010] [Indexed: 11/11/2022] Open
|
14
|
Rodríguez-Ferreiro J, Cuetos F, Herrera E, Menéndez M, Ribacoba R. Cognitive impairment in Parkinson's disease without dementia. Mov Disord 2010; 25:2136-41. [DOI: 10.1002/mds.23239] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
15
|
Tedrus GMAS, Fonseca LC, Kange PM. Parkinson's disease: Impact of clinical and cognitive aspects on quality of life. Dement Neuropsychol 2010; 4:131-137. [PMID: 29213676 PMCID: PMC5619172 DOI: 10.1590/s1980-57642010dn40200010] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2009] [Accepted: 04/14/2010] [Indexed: 11/26/2022] Open
Abstract
Parkinson's disease (PD) is a chronic disease manifested principally by motor signs and symptoms, but with frequent neuropsychological alterations. OBJECTIVES To study the relationship between clinical and cognitive aspects and the perception of quality of life (QOL) in PD patients. METHODS Twenty consecutive patients (13 men) with idiopathic PD (mean age: 64.5y), mean disease time of 7.8 years and at stages 1-3 according to the modified Hoehn and Yahr staging scale (HYS), all outpatients from the Neurology Department of the Celso Pierro General and Maternity Hospital (PUC-Campinas), were analyzed. The following were applied: a clinical-neurological assessment, the Mini-Mental State Examination (MMSE), standard neuropsychological battery of the CERAD (Consortium to Establish a Registry for Alzheimer's Disease), Hamilton Depression Rating Scale (HAM-D) and a QOL questionnaire (Parkinson's Disease Questionnaire - PDQ-39). Statistical analysis was carried out at a significance level of p<0.05. RESULTS On the PDQ-39 under the sections total, mobility and activities of daily living, and the items motor compromise (HYS) and language of the MMSE were predictors of worse QOL. Verbal fluency was a factor for emotional well-being on the PDQ-39, whereas higher scores for HAM-D and worse performance on the item attention and calculation of the MMSE were associated with worse QOL in the social support section. Total score on the MMSE and educational level were QOL factors in cognition. CONCLUSIONS The findings of the present study suggest that clinical, cognitive, motor or other depression-related factors contribute differently to the domains of QOL.
Collapse
Affiliation(s)
| | - Lineu Correa Fonseca
- Professor of Neurology, Pontifícia Universidade
Católica de Campinas, Campinas SP, Brazil (PUC-Campinas), Scholarship
holders
| | - Patrícia Mencaroni Kange
- Student of Faculty of Medicine with FAPIC placement
scholarship - Catholic University of Campinas (PUC-Campinas), Campinas SP,
Brazil
| |
Collapse
|
16
|
Tedrus GMAS, Fonseca LC, Letro GH, Bossoni AS, Adriana Bastos S. Dementia and mild cognitive impairment in Parkinson's disease. ARQUIVOS DE NEURO-PSIQUIATRIA 2010; 67:1164. [PMID: 20069239 DOI: 10.1590/s0004-282x2009000600038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
17
|
Caixeta L, Soares VL, Soares CD, Reis G. Dementia and mild cognitive impairment in Parkinson's disease. ARQUIVOS DE NEURO-PSIQUIATRIA 2009; 67:959. [PMID: 19838542 DOI: 10.1590/s0004-282x2009000500047] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Affiliation(s)
- Leonardo Caixeta
- Cognitive and Behavioral Neurology Unit, Hospital das Clínicas, Federal University of Goiás
| | | | | | | |
Collapse
|